Cancer Causes and Prevention
Covers known cancer risk factors, how certain cancers can be prevented, and ongoing research into causes and prevention.
Related Articles
Home | Multiple Myeloma Hub
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
Welcome! You are invited to join a webinar: Post-ASH 2024 CML highlights webinar. After registering, you will receive a confirmation email about joining the webinar.
Join us to watch leading CML experts present summaries on the most significant abstracts from ASH 2024 followed by interactive panel discussions debating current clinical…
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Can Immunotherapy Go the Distance in ES/LS Small-Cell Lung Cancer?
The FDA gave an accelerated OK to a BiTe therapy, but an IO-chemoRT combo was a non-starter
Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial
Baltimore Region: Due to the recent collapse of the Francis Scott Key Bridge, please anticipate delays when travelling to appointments. More information. Adding a personalized…
Trial of vaccine for triple-negative breast cancer yields ‘encouraging’ results
Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune response, according to updated results of a…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Zanidatamab Plus Evorpacept Shows Early Activity, Tolerability in Pretreated HER2+ Breast Cancer
Alberto Montero, MD, MBA, CPHQ, discusses early signals of efficacy and safety with zanidatamab plus evorpacept in HER2-positive and -low breast cancer.
SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number…
